Joseph Oliveto is President and CEO of Milestone Pharmaceuticals Inc.. Currently has a direct ownership of 482,744 shares of MIST, which is worth approximately $994,452. The most recent transaction as insider was on Jan 26, 2026, when has been sold 34,523 shares (Common Shares) at a price of $1.93 per share, resulting in proceeds of $66,629. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 483K
39.03% 3M change
n/a 12M change
Total Value Held $994,452

Joseph Oliveto Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 26 2026
SELL
Open market or private sale
$66,629 $1.93 p/Share
34,523 Reduced 6.67%
482,744 Common Shares
Jan 26 2026
BUY
Exercise of conversion of derivative security
-
66,600 Added 11.41%
517,267 Common Shares
Jan 08 2026
SELL
Open market or private sale
$96,750 $2.25 p/Share
43,000 Reduced 12.4%
303,721 Common Shares
Jan 07 2026
SELL
Open market or private sale
$1,125 $2.25 p/Share
500 Reduced 0.14%
346,721 Common Shares
Dec 15 2025
SELL
Open market or private sale
$308,685 $2.32 p/Share
133,054 Reduced 22.79%
450,667 Common Shares
Dec 12 2025
BUY
Grant, award, or other acquisition
-
280,000 Added 32.42%
583,721 Common Shares
Jul 11 2025
BUY
Grant, award, or other acquisition
-
66,666 Added 16.11%
347,221 Common Shares
JO

Joseph Oliveto

President and CEO
Montr?Al, A8

Track Institutional and Insider Activities on MIST

Follow Milestone Pharmaceuticals Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MIST shares.

Notify only if

Insider Trading

Get notified when an Milestone Pharmaceuticals Inc. insider buys or sells MIST shares.

Notify only if

News

Receive news related to Milestone Pharmaceuticals Inc.

Track Activities on MIST